Edwards Lifesciences reported $462.3M in Pre-Tax Profit for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Pre Tax Profit Change
Abbott ABT:US USD 2.17B 316M
Atricure ATRC:US USD -4049000 8.18M
Baxter International BAX:US USD 534M 13M
Becton, Dickinson and BDX:US USD 926.97M 25.03M
Boston Scientific BSX:US USD 745M 26M
Cardiovascular Systems CSII:US USD -7839000 2.81M
Cryolife CRY:US USD 3.28M 5.81M
Dexcom DXCM:US USD 179.9M 20.4M
Globus Medical GMED:US USD 74.56M 9.43M
Icu Medical ICUI:US USD 49.98M 57.52M
Inogen INGN:US USD -4308000 5.13M
Insulet PODD:US USD 22.3M 28M
Integra Lifesciences IART:US USD 95.19M 6.12M
Johnson & Johnson JNJ:US USD 7.42B 655M
Masimo MASI:US USD 94.4M 26.1M
Medtronic MDT:US USD 1.97B 1.76B
Nuvasive NUVA:US USD 31.42M 3.93M
Tandem Diabetes Care TNDM:US USD -16113000 379K
Zimmer Biomet Holdings Inc ZBH:US USD 476.7M 78.5M